1. DiaPark
Test System for Early Diagnostics of
Parkinson’s Disease
DiaPark
Razina Nigmatullina
deputy CEO,
LLC “Centre for the early diagnostics
of the neurodegenerative diseases”
Kazan, Russian Federation
razinar@mail.ru
+7 (927) 429 04 66

2. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 2
0
20
60
80
40
100
%
0
20
60
80
40
100
10 20 807060504030
%, Neurons
Neuronal cell death
THE FIRST SYMPTOMS
ONSET OF THE DISEASE
Compensatory
mechanisms
Development objectives:
 Early diagnostics;
 Preventive treatment.
Limb tremor (tremor). Violation
and stiffness of gait and speech
Trends:
1. Shift towards younger patients, 15% of the patients are <40 years;
2. The aging of the population.
World population older than 60 years: in 2010 10%, 2040 25% of the
population.
Caring for the growing number of patients is very expensive
Age
PARKINSON'S DISEASE IS INSIDIOUS:
WHEN SYMPTOMS START APPEARING, IT IS IMPOSSIBLE TO CURE

3. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 3
DiaPark – COST-EFFECTIVE EARLY WARNING SYSTEM
Test Kit:
1. Immunological chips;
2. Genetic chips;
3. Electrophysiological tests
(EEG, ECG, EMG + program).
 Cost-effective, mass, preventive care;
 Only selective diagnostics on expensive PET scan;
 Treatment of earlier stage disease effectively and cheaply.
Newly developed technology allows detection of Parkinson's disease
for several years before the appearance of specific symptoms

4. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 4
METHOD DiaPark IS ECONOMICALLY FEASIBLE
FOR MASS DIAGNOSTICS
Radiation safety
The survey of large
population groups
Accuracy Price
DiaPark 85- 90% $150
PET 98-100% $6000
DiaPark
$150 / patient
PET
$6000 / patient
1 million
DiaPark
25 thousand PET
Improving the lives of millions and savings billions in money
?
?

5. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 5
THE TEAM OF PROFESSIONALS
Ugrumov M.V. – CEO, CSO.
 International experience in
Neuroscience. More than 25
years of work in France,
Japan, Germany and USA;
 Author of 250 articles in
leading international journals.
Nigmatullina R.R. - COO.
 International experience;
 Improving competencies
of technology
commercialization «Fast
trac Planning»;
 Ph.D., professor.
Under the guidance of Academician M.V.Ugrumov team working from 2005 on the
oject "Neurodegenerative diseases: development of preclinical diagnostics and preventive treatment
"
Georgieva S.G. PhD., Slominsky P.A., PhD. - Examination of gene expression;
Kudrin V.S. PhD., Pronina T.S. PhD.- Determination of monoamines and hormones;
Obukhov Y.V., PhD. - Electrophysiology, mathematical processing, informatics
technologies;

6. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 6
YOU HAVE A CHANCE FOR INVESTING $2 MILLION IN
DiaPark
1. The project is at the stage prototype development.
Attracted $800 thousand of R&D funding through Federal Target Programs
and grants;
Grants and investments raised so far $200 thousand;
2. $2 million will be spent on:
 Clinical trials in Russia, Europe and the USA
 International patenting
 Product certification and registration
 Marketing
 Promotion of products on the world market
3. Output:
Attracting investors for the next stage in the global market;
Sale to a strategic investor (Amarantus BioSciences, Rainbow BioSciences, etc.).

7. DiaPark Test System For Early Diagnostics Of Parkinson’s Disease 7
EARLY DIAGNOSTICS OF PARKINSON'S DISEASE
MAY SAVE YOUR LIFE!
DiaPark:
1. Saves human lives
2. Saves money in healthcare
3. Offers You a great investment opportunity
Razina Nigmatullina
deputy CEO,
LLC “Centre for the early diagnostics of the neurodegenerative
diseases”
Kazan, Russian Federation
razinar@mail.ru
+7 (927) 429 04 66